Epidemiological and transcriptomic observations suggest that the increased incidence of autoimmunity from MDA5+ and ILD that occurred simultaneously during COVID-19 could be related to an aberrant IFN type 1 - centric response. The gene discussed is IFIH1; the disease is COVID-19.